Načítá se...
Anti-epidermal or anti-vascular endothelial growth factor as first-line metastatic colorectal cancer in modified Glasgow prognostic score 2' patients
BACKGROUND: In metastatic colorectal cancer, the modified Glasgow prognostic score (mGPS) has been approved as an independent prognostic indicator of survival. No data existed on poor prognosis patients treated with molecular-targeted agents. METHODS: From January 2007 to February 2012, patients wit...
Uloženo v:
| Vydáno v: | J Cachexia Sarcopenia Muscle |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4575554/ https://ncbi.nlm.nih.gov/pubmed/26401469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12022 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|